The global equine veterinary therapeutics market is expected to expand significantly and generate revenue of US$ 2,671.9 million by 2033 from US$ 1,378.7 million in 2023. This increase in revenue is made with an impressive CAGR value of 6.8%.
Historically the equine veterinary therapeutics market is generated US$ 1,307.6 million in 2022. There is expanding popularity of horse activities like racing and jumping which makes demand for equine veterinary therapeutics for care and treatment for horses if any horse gets any injury in these activities.
Equine veterinary therapy is a broad word that covers a wide range of horse therapies. These medicines have the potential to prevent, diagnose, and cure a wide range of diseases and medical conditions.
Horse owners are investing a large amount of money in the health of their animals as they are becoming more aware of the importance of care and treatment of their horses which brings the growth of the equine veterinary therapeutics market.
Regulations governing the use of horse veterinary medications have been established by governments. These rules are intended to ensure both the security and the effectiveness of these health care products. This is predicted to support the expansion of the equine veterinary treatments market, as owners of animals will be more willing to utilize medications that have received approval from the government.
| Report Attribute | Details |
|---|---|
| Equine Veterinary Therapeutics Market Value (2023) | US$ 1,378.7 million |
| Equine Veterinary Therapeutics Market Anticipated Forecast Value (2033) | US$ 2,671.9 million |
| Equine Veterinary Therapeutics Market Projected Growth Rate (2023 to 2033) | 6.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global equine veterinary therapeutics market expanded significantly from a revenue of US$ 1,052.2 million in 2017 to US$ 1,307.6 million in 2022 with an impressive CAGR of 4.4% during the historical period 2017 to 2022.
The global equestrian sports business is quickly expanding, which is fueling demand for equine veterinarian services. Horses are utilized in many sports, such as racing, show jumping, and dressage. These activities necessitate horses in peak physical condition, which increases the demand for preventative and therapeutic veterinary services.
Innovative Growth Strategies by Key Players to Thrive in the Competition
Investment Opportunities in the Industry
North America is the largest horse veterinary treatments market, accounting for 30.7% value share in global market. It is likely to expand more in the next decade. The veterinary treatments market in North America is expanding due to increased demand for anti-infectives, vaccinations, pain medications, digestive aids, and the strong research and development industry in North America, are driving the market.
| Country | The United States |
|---|---|
| 2022 value share in Global Market | 24.7% |
The European market for horse veterinary medications is extremely fragmented and has a value share of 35.2% in 2022, with many small and medium-sized businesses. However, a few huge international corporations play a significant influence in the industry. Many Europe companies manufacture horse goods including immunizations, antibiotics, anti-inflammatory medicines, and pain medications.
| Country | United Kingdom |
|---|---|
| Value CAGR (2023 to 2033) | 4.8% |
| Country | Germany |
|---|---|
| 2022 value share in Global Market | 6.2% |
The adoption of technology is also playing a significant role in the growth of the Asia Pacific equine veterinary therapeutics market. New technologies are being developed that have the potential to transform the treatment of horse illnesses, like gene therapy, immunotherapy, and customized medicine. These technologies are projected to play a significant role in market growth in the future years in the region.
| Country | Japan |
|---|---|
| 2022 value share in Global Market | 4.4% |
| Country | Value CAGR (2023 to 2033) |
|---|---|
| China | 8.3% |
| India | 6.8% |
Principal Consultant
| Segment Name | Segment Share |
|---|---|
| Topical | 43.2 |
| Veterinary Clinics | 40.5 |
With the increased demand for anti-infectives, pain relievers, and digestive aid products, the topical section of the veterinary treatments market is expanding and has a segment share of 43.2%. The rising frequency of infectious illnesses, rising prevalence of chronic diseases, and rising pet obesity rates are all boosting demand for these items.
With rising demand for surgery, diagnostic testing, and preventive care, the veterinary clinics sector of the veterinary treatments market is expanding and has a segment share of 40.5%. The rising prevalence of animal injuries and diseases, the increased availability of diagnostic testing, and the expanding understanding of the value of preventative treatment are all boosting demand for these services.
Recent Developments
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The equine veterinary therapeutics market is expected to expand at a CAGR of 6.8% from 2023 to 2033.
North America is the leading region in the global equine veterinary therapeutics market.
The global equine veterinary therapeutics market was valued at US$ 1,378.7 million in 2023.
The anticipated revenue of the equine veterinary therapeutics market until 2033 is US$ 2,671.9 million.
Zoetis, Boehringer Ingelheim, Merck Animal Health, Virbac, Elanco Animal Health, and Ceva Animal Health are prominent market manufacturers.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drugs 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Drugs, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drugs, 2023 to 2033 5.3.1. Anti- Inflammatory 5.3.2. Anti – Infective 5.3.3. Parasiticides 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Drugs, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Drugs, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Vaccines 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Vaccines, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Vaccines, 2023 to 2033 6.3.1. Recombinant vaccines 6.3.2. Inactivated Vaccines 6.3.3. Live attenuated vaccines 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Vaccines, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Vaccines, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Feed Additives 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Feed Additives, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Feed Additives, 2023 to 2033 7.3.1. Vitamins 7.3.2. Antibiotics 7.3.3. Amino acids 7.3.4. Enzymes 7.3.5. Others 7.4. Y-o-Y Growth Trend Analysis By Feed Additives, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Feed Additives, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033 8.3.1. Oral 8.3.2. Parental 8.3.3. Topical 8.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 9.3.1. Veterinary Hospital 9.3.2. Veterinary Clinics 9.3.3. Pharmacies and drug stores 9.3.4. E-commerce 9.3.5. Other 9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022 9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Western Europe 10.3.4. Eastern Europe 10.3.5. South Asia and Pacific 10.3.6. East Asia 10.3.7. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. USA 11.2.1.2. Canada 11.2.2. By Drugs 11.2.3. By Vaccines 11.2.4. By Feed Additives 11.2.5. By Route of Administration 11.2.6. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Drugs 11.3.3. By Vaccines 11.3.4. By Feed Additives 11.3.5. By Route of Administration 11.3.6. By Distribution Channel 11.4. Key Takeaways 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Drugs 12.2.3. By Vaccines 12.2.4. By Feed Additives 12.2.5. By Route of Administration 12.2.6. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Drugs 12.3.3. By Vaccines 12.3.4. By Feed Additives 12.3.5. By Route of Administration 12.3.6. By Distribution Channel 12.4. Key Takeaways 13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. UK 13.2.1.3. France 13.2.1.4. Spain 13.2.1.5. Italy 13.2.1.6. Rest of Western Europe 13.2.2. By Drugs 13.2.3. By Vaccines 13.2.4. By Feed Additives 13.2.5. By Route of Administration 13.2.6. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Drugs 13.3.3. By Vaccines 13.3.4. By Feed Additives 13.3.5. By Route of Administration 13.3.6. By Distribution Channel 13.4. Key Takeaways 14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Poland 14.2.1.2. Russia 14.2.1.3. Czech Republic 14.2.1.4. Romania 14.2.1.5. Rest of Eastern Europe 14.2.2. By Drugs 14.2.3. By Vaccines 14.2.4. By Feed Additives 14.2.5. By Route of Administration 14.2.6. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Drugs 14.3.3. By Vaccines 14.3.4. By Feed Additives 14.3.5. By Route of Administration 14.3.6. By Distribution Channel 14.4. Key Takeaways 15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Bangladesh 15.2.1.3. Australia 15.2.1.4. New Zealand 15.2.1.5. Rest of South Asia and Pacific 15.2.2. By Drugs 15.2.3. By Vaccines 15.2.4. By Feed Additives 15.2.5. By Route of Administration 15.2.6. By Distribution Channel 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Drugs 15.3.3. By Vaccines 15.3.4. By Feed Additives 15.3.5. By Route of Administration 15.3.6. By Distribution Channel 15.4. Key Takeaways 16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. China 16.2.1.2. Japan 16.2.1.3. South Korea 16.2.2. By Drugs 16.2.3. By Vaccines 16.2.4. By Feed Additives 16.2.5. By Route of Administration 16.2.6. By Distribution Channel 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Drugs 16.3.3. By Vaccines 16.3.4. By Feed Additives 16.3.5. By Route of Administration 16.3.6. By Distribution Channel 16.4. Key Takeaways 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 17.2.1. By Country 17.2.1.1. GCC Countries 17.2.1.2. South Africa 17.2.1.3. Israel 17.2.1.4. Rest of MEA 17.2.2. By Drugs 17.2.3. By Vaccines 17.2.4. By Feed Additives 17.2.5. By Route of Administration 17.2.6. By Distribution Channel 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Drugs 17.3.3. By Vaccines 17.3.4. By Feed Additives 17.3.5. By Route of Administration 17.3.6. By Distribution Channel 17.4. Key Takeaways 18. Key Countries Market Analysis 18.1. USA 18.1.1. Pricing Analysis 18.1.2. Market Share Analysis, 2022 18.1.2.1. By Drugs 18.1.2.2. By Vaccines 18.1.2.3. By Feed Additives 18.1.2.4. By Route of Administration 18.1.2.5. By Distribution Channel 18.2. Canada 18.2.1. Pricing Analysis 18.2.2. Market Share Analysis, 2022 18.2.2.1. By Drugs 18.2.2.2. By Vaccines 18.2.2.3. By Feed Additives 18.2.2.4. By Route of Administration 18.2.2.5. By Distribution Channel 18.3. Brazil 18.3.1. Pricing Analysis 18.3.2. Market Share Analysis, 2022 18.3.2.1. By Drugs 18.3.2.2. By Vaccines 18.3.2.3. By Feed Additives 18.3.2.4. By Route of Administration 18.3.2.5. By Distribution Channel 18.4. Mexico 18.4.1. Pricing Analysis 18.4.2. Market Share Analysis, 2022 18.4.2.1. By Drugs 18.4.2.2. By Vaccines 18.4.2.3. By Feed Additives 18.4.2.4. By Route of Administration 18.4.2.5. By Distribution Channel 18.5. Germany 18.5.1. Pricing Analysis 18.5.2. Market Share Analysis, 2022 18.5.2.1. By Drugs 18.5.2.2. By Vaccines 18.5.2.3. By Feed Additives 18.5.2.4. By Route of Administration 18.5.2.5. By Distribution Channel 18.6. UK 18.6.1. Pricing Analysis 18.6.2. Market Share Analysis, 2022 18.6.2.1. By Drugs 18.6.2.2. By Vaccines 18.6.2.3. By Feed Additives 18.6.2.4. By Route of Administration 18.6.2.5. By Distribution Channel 18.7. France 18.7.1. Pricing Analysis 18.7.2. Market Share Analysis, 2022 18.7.2.1. By Drugs 18.7.2.2. By Vaccines 18.7.2.3. By Feed Additives 18.7.2.4. By Route of Administration 18.7.2.5. By Distribution Channel 18.8. Spain 18.8.1. Pricing Analysis 18.8.2. Market Share Analysis, 2022 18.8.2.1. By Drugs 18.8.2.2. By Vaccines 18.8.2.3. By Feed Additives 18.8.2.4. By Route of Administration 18.8.2.5. By Distribution Channel 18.9. Italy 18.9.1. Pricing Analysis 18.9.2. Market Share Analysis, 2022 18.9.2.1. By Drugs 18.9.2.2. By Vaccines 18.9.2.3. By Feed Additives 18.9.2.4. By Route of Administration 18.9.2.5. By Distribution Channel 18.10. Poland 18.10.1. Pricing Analysis 18.10.2. Market Share Analysis, 2022 18.10.2.1. By Drugs 18.10.2.2. By Vaccines 18.10.2.3. By Feed Additives 18.10.2.4. By Route of Administration 18.10.2.5. By Distribution Channel 18.11. Russia 18.11.1. Pricing Analysis 18.11.2. Market Share Analysis, 2022 18.11.2.1. By Drugs 18.11.2.2. By Vaccines 18.11.2.3. By Feed Additives 18.11.2.4. By Route of Administration 18.11.2.5. By Distribution Channel 18.12. Czech Republic 18.12.1. Pricing Analysis 18.12.2. Market Share Analysis, 2022 18.12.2.1. By Drugs 18.12.2.2. By Vaccines 18.12.2.3. By Feed Additives 18.12.2.4. By Route of Administration 18.12.2.5. By Distribution Channel 18.13. Romania 18.13.1. Pricing Analysis 18.13.2. Market Share Analysis, 2022 18.13.2.1. By Drugs 18.13.2.2. By Vaccines 18.13.2.3. By Feed Additives 18.13.2.4. By Route of Administration 18.13.2.5. By Distribution Channel 18.14. India 18.14.1. Pricing Analysis 18.14.2. Market Share Analysis, 2022 18.14.2.1. By Drugs 18.14.2.2. By Vaccines 18.14.2.3. By Feed Additives 18.14.2.4. By Route of Administration 18.14.2.5. By Distribution Channel 18.15. Bangladesh 18.15.1. Pricing Analysis 18.15.2. Market Share Analysis, 2022 18.15.2.1. By Drugs 18.15.2.2. By Vaccines 18.15.2.3. By Feed Additives 18.15.2.4. By Route of Administration 18.15.2.5. By Distribution Channel 18.16. Australia 18.16.1. Pricing Analysis 18.16.2. Market Share Analysis, 2022 18.16.2.1. By Drugs 18.16.2.2. By Vaccines 18.16.2.3. By Feed Additives 18.16.2.4. By Route of Administration 18.16.2.5. By Distribution Channel 18.17. New Zealand 18.17.1. Pricing Analysis 18.17.2. Market Share Analysis, 2022 18.17.2.1. By Drugs 18.17.2.2. By Vaccines 18.17.2.3. By Feed Additives 18.17.2.4. By Route of Administration 18.17.2.5. By Distribution Channel 18.18. China 18.18.1. Pricing Analysis 18.18.2. Market Share Analysis, 2022 18.18.2.1. By Drugs 18.18.2.2. By Vaccines 18.18.2.3. By Feed Additives 18.18.2.4. By Route of Administration 18.18.2.5. By Distribution Channel 18.19. Japan 18.19.1. Pricing Analysis 18.19.2. Market Share Analysis, 2022 18.19.2.1. By Drugs 18.19.2.2. By Vaccines 18.19.2.3. By Feed Additives 18.19.2.4. By Route of Administration 18.19.2.5. By Distribution Channel 18.20. South Korea 18.20.1. Pricing Analysis 18.20.2. Market Share Analysis, 2022 18.20.2.1. By Drugs 18.20.2.2. By Vaccines 18.20.2.3. By Feed Additives 18.20.2.4. By Route of Administration 18.20.2.5. By Distribution Channel 18.21. GCC Countries 18.21.1. Pricing Analysis 18.21.2. Market Share Analysis, 2022 18.21.2.1. By Drugs 18.21.2.2. By Vaccines 18.21.2.3. By Feed Additives 18.21.2.4. By Route of Administration 18.21.2.5. By Distribution Channel 18.22. South Africa 18.22.1. Pricing Analysis 18.22.2. Market Share Analysis, 2022 18.22.2.1. By Drugs 18.22.2.2. By Vaccines 18.22.2.3. By Feed Additives 18.22.2.4. By Route of Administration 18.22.2.5. By Distribution Channel 18.23. Israel 18.23.1. Pricing Analysis 18.23.2. Market Share Analysis, 2022 18.23.2.1. By Drugs 18.23.2.2. By Vaccines 18.23.2.3. By Feed Additives 18.23.2.4. By Route of Administration 18.23.2.5. By Distribution Channel 19. Market Structure Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Market Share Analysis of Top Players 19.3.1. By Regional 19.3.2. By Drugs 19.3.3. By Vaccines 19.3.4. By Feed Additives 19.3.5. By Route of Administration 19.3.6. By Distribution Channel 20. Competition Analysis 20.1. Competition Deep Dive 20.1.1. Merck Animal Heath 20.1.1.1. Overview 20.1.1.2. Product Portfolio 20.1.1.3. Profitability by Market Segments 20.1.1.4. Sales Footprint 20.1.1.5. Strategy Overview 20.1.1.5.1. Marketing Strategy 20.1.2. Affymetrix 20.1.2.1. Overview 20.1.2.2. Product Portfolio 20.1.2.3. Profitability by Market Segments 20.1.2.4. Sales Footprint 20.1.2.5. Strategy Overview 20.1.2.5.1. Marketing Strategy 20.1.3. Elanco Animal Health 20.1.3.1. Overview 20.1.3.2. Product Portfolio 20.1.3.3. Profitability by Market Segments 20.1.3.4. Sales Footprint 20.1.3.5. Strategy Overview 20.1.3.5.1. Marketing Strategy 20.1.4. Zoetis (Pfizer Animal Health) 20.1.4.1. Overview 20.1.4.2. Product Portfolio 20.1.4.3. Profitability by Market Segments 20.1.4.4. Sales Footprint 20.1.4.5. Strategy Overview 20.1.4.5.1. Marketing Strategy 20.1.5. Equine Health UK 20.1.5.1. Overview 20.1.5.2. Product Portfolio 20.1.5.3. Profitability by Market Segments 20.1.5.4. Sales Footprint 20.1.5.5. Strategy Overview 20.1.5.5.1. Marketing Strategy 20.1.6. Olympia Equine Veterinary Services PLLC 20.1.6.1. Overview 20.1.6.2. Product Portfolio 20.1.6.3. Profitability by Market Segments 20.1.6.4. Sales Footprint 20.1.6.5. Strategy Overview 20.1.6.5.1. Marketing Strategy 20.1.7. Ceva Sante Animale 20.1.7.1. Overview 20.1.7.2. Product Portfolio 20.1.7.3. Profitability by Market Segments 20.1.7.4. Sales Footprint 20.1.7.5. Strategy Overview 20.1.7.5.1. Marketing Strategy 20.1.8. Eli Lilly and Company 20.1.8.1. Overview 20.1.8.2. Product Portfolio 20.1.8.3. Profitability by Market Segments 20.1.8.4. Sales Footprint 20.1.8.5. Strategy Overview 20.1.8.5.1. Marketing Strategy 20.1.9. Virbac 20.1.9.1. Overview 20.1.9.2. Product Portfolio 20.1.9.3. Profitability by Market Segments 20.1.9.4. Sales Footprint 20.1.9.5. Strategy Overview 20.1.9.5.1. Marketing Strategy 20.1.10. Bayer AG 20.1.10.1. Overview 20.1.10.2. Product Portfolio 20.1.10.3. Profitability by Market Segments 20.1.10.4. Sales Footprint 20.1.10.5. Strategy Overview 20.1.10.5.1. Marketing Strategy 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Equine Veterinary Therapeutics Market
